Pulmonx Corp. (LUNG) Social Stream
PULMONX CORP (LUNG) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PULMONX CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 6 | $72 | $45 | $56.857 | $12.93 | 339.73% |
| 2021-12-08 | 5 | $65 | $45 | $54.333 | $12.93 | 320.21% |
| 2022-01-07 | 5 | $65 | $37 | $52.5 | $12.93 | 306.03% |
| 2022-02-24 | 6 | $60 | $30 | $45 | $12.93 | 248.03% |
| 2022-03-01 | 6 | $60 | $28 | $42.571 | $12.93 | 229.24% |
| 2022-03-31 | 6 | $55 | $28 | $39.666 | $12.93 | 206.77% |
| 2022-04-11 | 5 | $55 | $28 | $39.666 | $12.93 | 206.77% |
| 2022-05-04 | 5 | $55 | $28 | $39.166 | $12.93 | 202.91% |
| 2022-06-09 | 5 | $55 | $23 | $36.857 | $12.93 | 185.05% |
| 2022-07-18 | 6 | $55 | $19 | $33 | $12.93 | 155.22% |
| 2022-08-03 | 6 | $55 | $19 | $28.285 | $12.93 | 118.75% |
| 2022-10-03 | 6 | $55 | $19 | $27.857 | $12.93 | 115.44% |
| 2022-10-11 | 6 | $55 | $19 | $27.571 | $12.93 | 113.23% |
| 2022-11-04 | 5 | $19 | $13 | $15.666 | $12.93 | 21.16% |
| 2022-11-14 | 5 | $19 | $8 | $13.833 | $12.93 | 6.98% |
| 2022-12-12 | 6 | $16 | $8 | $12.333 | $12.93 | -4.62% |
| 2023-01-03 | 6 | $16 | $6 | $11.428 | $12.93 | -11.62% |
| 2023-02-08 | 6 | $16 | $6 | $10.785 | $12.93 | -16.59% |
| 2023-02-24 | 7 | $20 | $6 | $11.857 | $12.93 | -8.3% |
| 2023-02-26 | 7 | $20 | $6 | $11.857 | $12.93 | -8.3% |
| 2023-05-02 | 7 | $20 | $8 | $13.142 | $12.93 | 1.64% |
| 2023-05-05 | 7 | $20 | $8 | $14.142 | $12.93 | 9.37% |
| 2023-06-06 | 6 | $20 | $8 | $14.166 | $12.93 | 9.56% |
| 2023-07-10 | 6 | $20 | $8 | $14.5 | $12.93 | 12.14% |
| 2023-08-03 | 6 | $20 | $8 | $15.166 | $12.93 | 17.29% |
| 2023-10-30 | 7 | $20 | $8 | $15.571 | $12.93 | 20.43% |
| 2023-11-01 | 7 | $18 | $8 | $13.857 | $12.93 | 7.17% |
The Trend in the Analyst Price Target
Over the past 36 weeks, LUNG's average price target has gone up $2.
Over the past 40 weeks, LUNG's average upside potential has been 30.9%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 6 | 16 | 6 | 10.785 | 9.20 | 17.23% |
| 2023-02-24 | 7 | 20 | 6 | 11.857 | 10.37 | 14.34% |
| 2023-02-26 | 7 | 20 | 6 | 11.857 | 10.37 | 14.34% |
| 2023-05-02 | 7 | 20 | 8 | 13.142 | 11.47 | 14.58% |
| 2023-05-05 | 6 | 20 | 8 | 14.166 | 12.29 | 15.26% |
LUNG Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.43 | 6 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
LUNG's average broker recommendation rating improved by 0.57 over the prior 20 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PULMONX CORP's variance in analysts' estimates is lower than -2212.42% of them.
- PULMONX CORP's upside potential (average analyst target price relative to current price) is higher than 1814.79% of all US stocks.
- In terms of how PULMONX CORP fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 1055.87% of that group.
- In the context of stocks in the mid market cap category, PULMONX CORP's number of analysts covering the stock is higher than 917.04% of them.
Stocks similar to PULMONX CORP in the Medical Equipment industry regarding analyst recommendations and price targets are NVST, EYE, and STAA.
View All Top Stocks by Price Target
Is LUNG a Buy, Hold or Sell? See the POWR Ratings now!